Haw Par (SGX:H02) FCF Margin % : 33.37% (As of Dec. 2023)

View and export this data going back to 1969. Start your Free Trial

What is Haw Par FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Haw Par's Free Cash Flow for the six months ended in Dec. 2023 was S$40.4 Mil. Haw Par's Revenue for the six months ended in Dec. 2023 was S$120.9 Mil. Therefore, Haw Par's FCF Margin % for the quarter that ended in Dec. 2023 was 33.37%.

As of today, Haw Par's current FCF Yield % is 2.54%.

The historical rank and industry rank for Haw Par's FCF Margin % or its related term are showing as below:

SGX:H02' s FCF Margin % Range Over the Past 10 Years
Min: 10.24 Med: 27.53 Max: 68.82
Current: 23.66

During the past 13 years, the highest FCF Margin % of Haw Par was 68.82%. The lowest was 10.24%. And the median was 27.53%.

SGX:H02's FCF Margin % is ranked better than
93.26% of 1024 companies
in the Drug Manufacturers industry
Industry Median: 0.195 vs SGX:H02: 23.66

Haw Par FCF Margin % Historical Data

The historical data trend for Haw Par's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Haw Par FCF Margin % Chart

Haw Par Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

33.28

15.75

10.24

11.65

23.66

Haw Par Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Margin %	Get a 7-Day Free Trial															9.97	13.17	9.97	13.10	33.37

Competitive Comparison of Haw Par's FCF Margin %

For the Drug Manufacturers - General subindustry, Haw Par's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Haw Par's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Haw Par's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Haw Par's FCF Margin % falls into.

Haw Par FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Haw Par's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	54.916	/	232.062
	=	23.66 %

Haw Par's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	40.354	/	120.939
	=	33.37 %

Haw Par FCF Margin % Related Terms

Thank you for viewing the detailed overview of Haw Par's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Haw Par (SGX:H02) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Haw Par Corp Ltd (SGX:H02) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

HAWPF:USA

Address

401 Commonwealth Drive, No. 03-03 Haw Par Technocentre, Singapore, SGP, 149598

Website

https://www.hawpar.com

Haw Par Corp Ltd is a drug manufacturing company that operates multiple brands. The company is to expand its core businesses through product brand extension, strategic alliances, and exploring potential acquisitions. Its operating segments include the Healthcare segment, Investments segment, and Others segment. The company generates maximum revenue from the Healthcare segment. Its Healthcare segment manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brands. Geographically, it generates a majority of its revenue from the ASEAN countries.

Haw Par (SGX:H02) Headlines

No Headlines